IMARC Group, a leading market research company, has recently releases report titled “Array Instruments Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global array instruments market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. Report Highlights
How big is the array instruments market?
Report Attributes | Details |
Market Size in 2022 | US$ 1.1 Billion |
Market Forecast in 2028 | US$ 1.4 Billion |
Growth rate (2023 to 2028) | CAGR of 3.2% |
Base Year of the Analysis | 2022 |
Forecast Period | 2023-2028 |
What is array instruments?
Array instruments are devices that are used to collect microscopic spots of RNA, DNA, proteins, tissues, peptides, oligonucleotides, cells, and other compounds attached to a solid substrate. They are utilized in laboratories that quantitatively and simultaneously monitor the expression of multiple genes. The high-throughput approach of array technology helps to locate mutations and chromosomal expressions in a genotype, and measure and detect gene expressions at the messenger RNA (mRNA) or the protein level. Request for a free sample copy of this report: https://www.imarcgroup.com/array-instruments-market/requestsampleWhat are the growth prospects and trends in the array instruments industry?
The primary factors driving the array instruments market are the emerging need for diagnosing cancer, post-natal and different metabolic diseases. These instruments assist in hybridization, coupling biomolecules to a platform, sample preparation for detection, data analysis, and scanning, which have increased their demand in recent times. Furthermore, governments across the globe have undertaken several initiatives to improve the healthcare infrastructure and increase investments in research and development (R&D) activities, which in turn have boosted the demand for array instruments. Moreover, the introduction of the latest technologies, such as microarray-based comparative genomic hybridization, has enhanced the process of single nucleotide polymorphism (SNP) and offers accuracy and precision in disease diagnosis and drug discovery, which in turn is expected to provide a positive impact on the industry.What is included in market segmentation?
The report has segmented the market into the following categories: Breakup by Application:- Molecular Biology
- Cell Biology
- Genetics
- Molecular Pathology
- Others
- DNA Microarrays
- Protein Microarrays
- Cellular Microarrays
- Tissue Microarrays
- Research and Development Laboratories
- Clinical Diagnostic Labs
- Agriculture Research Centers
- Veterinary Laboratories
- Forensic Centers
- Others
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Who are the key players operating in the industry?
The report covers the major market players including:- Affymetrix Inc.
- Agilent Technologies Inc.
- Arrayit Corporation
- Bio-RAD Laboratories Inc.
- Illumina Inc.
- Laboratory Corporation
- Molecular Devices LLC
- Raybiotech Inc.
- Sigma Aldrich Corporation
- Thermo Fisher Scientific Inc.